ScoreWhy is Sanofi India Ltd ?
1
High Management Efficiency with a high ROE of 49.40%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of -8.47% and Operating profit at -5.55% over the last 5 years
4
Flat results in Sep 25
5
With ROE of 47.4, it has a Very Attractive valuation with a 11.8 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -26.72%, its profits have fallen by -0.9%
- At the current price, the company has a high dividend yield of 4.8
6
High Institutional Holdings at 26.86%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Below par performance in long term as well as near term
- Along with generating -26.72% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sanofi India should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sanofi India for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sanofi India
-26.72%
-1.23
21.64%
Sensex
8.49%
0.74
11.41%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-8.47%
EBIT Growth (5y)
-5.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
2.17
Tax Ratio
26.37%
Dividend Payout Ratio
65.08%
Pledged Shares
0
Institutional Holding
26.86%
ROCE (avg)
116.06%
ROE (avg)
49.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
32
Price to Book Value
11.85
EV to EBIT
18.63
EV to EBITDA
17.28
EV to Capital Employed
18.30
EV to Sales
4.64
PEG Ratio
NA
Dividend Yield
4.77%
ROCE (Latest)
95.33%
ROE (Latest)
47.39%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bearish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
PAT(9M)
Higher at Rs 285.28 Cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sanofi India
Profit After Tax (PAT) - Nine Monthly
At Rs 285.28 cr has Grown at 54.80%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 285.28 Cr
than preceding 12 month period ended Sep 2025 of Rs 269.61 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
